Jefferies Defends Disc Medicine (IRON): 'Overreaction to Article on IRON EPP Approvability Under CNPV'
Tweet Send to a Friend
Jefferies analyst Roger Song reiterated a Buy rating and $154.00 price target on Disc Medicine (NASDAQ: IRON)The analyst comments "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
